Statistical evaluation of CZE-UV and CZE-ESI-MS data of intact α-1-acid glycoprotein isoforms for their use as potential biomarkers in bladder cancer.
about
Analysis of alpha-1-acid glycoprotein isoforms using CE-LIF with fluorescent thiol derivatization.Recent advances in the combination of capillary electrophoresis with mass spectrometry: from element to single-cell analysis.CE-MS for the analysis of intact proteins 2010-2012.Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selectionFucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer.Growing trend of CE at the omics level: the frontier of systems biology--an update.Capillary electrophoresis/mass spectrometry relevant to pharmaceutical and biotechnological applications.On-line CE/ESI/MS interfacing: recent developments and applications in proteomics.Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.Application of capillary electrophoresis for the early diagnosis of cancer.Developing proteomic biomarkers for bladder cancer: towards clinical application.Multivariate statistics for the differentiation of erythropoietin preparations based on intact glycoforms determined by CE-MS.Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype.Glycoform analysis of alpha1-acid glycoprotein based on capillary electrophoresis and electrophoretic injection.Screening of Small Intact Proteins by Capillary Electrophoresis Electrospray Ionization-Mass Spectrometry (CE-ESI-MS).CE methods for analysis of isoforms of prostate-specific antigen compatible with online derivatization for LIF detection
P2860
Q34249119-FEE66592-0130-4FB9-93AC-446F806A011AQ34480649-7F4853D9-BC6E-4ABF-A8D4-90E389A0827DQ34480662-1F11D71E-FCD9-43EF-8217-33CEB9CE01C4Q34916073-50B3570A-1479-418A-93D5-CCFE4C6449ADQ36050468-E1FFA7A6-A8E2-4949-8029-6C2634EE25ABQ37706879-7C018FB6-EAA9-40EE-AFB5-E3D3B5839908Q37964549-F1DD48A3-98E9-41DA-A7C3-B31EA0B77E99Q38021959-6E97A752-05D6-4D15-8ABF-DFF198CC2797Q38034203-4B73460D-3890-43C0-9F89-3D7F7136EC23Q38130892-62B53AF1-7BC4-457A-A8BB-DF3AC490B1E5Q38199367-BF0995A0-55AB-461D-B4DF-012E85191127Q38511509-585172C9-CC38-4C58-9E5C-692BAC99B93AQ39376945-500780C3-18CA-4FD7-A68E-5C96578DF5E0Q41478869-6B4027FF-5B3B-4B3A-84CA-7340B5EF8E5FQ47900373-DBC52C54-4ABB-473C-8B00-FD520EFA25CAQ51606405-BAB1E7B8-E339-4E27-9410-DE01176443BAQ57558627-77CAEFF9-4DAB-4AE6-9F16-87953F9BC046
P2860
Statistical evaluation of CZE-UV and CZE-ESI-MS data of intact α-1-acid glycoprotein isoforms for their use as potential biomarkers in bladder cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@ast
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@en
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@nl
type
label
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@ast
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@en
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@nl
prefLabel
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@ast
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@en
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@nl
P2093
P2860
P356
P1433
P1476
Statistical evaluation of CZE- ...... biomarkers in bladder cancer.
@en
P2093
Christian Neusüss
Pedro J Martín-Álvarez
Sara Ongay
P2860
P304
P356
10.1002/ELPS.201000244
P577
2010-10-01T00:00:00Z